Author: Anonymous

John is scheduled for elective right total knee replacement in two weeks. He is scheduled for preoperative clearance with you today. During review of his past medical history, you see that John has a significant cardiovascular disease history (hypertension, hyperlipidemia, coronary artery disease) and that he recently (2 months prior) had two drug-eluting stents placed in his heart following a heart attack. John tells you that he remembers the orthopedic surgery nurse team stating he should discontinue his antiplatelet medications at least a week prior to the procedure. Medication List – metoprolol succinate, valsartan, atorvastatin, amlodipine, ticagrelor, aspirin As the provider tasked with managing his preoperative clearance, what is the correct course of action?

What does S.M.A.R.T Goals stand for? 

Someone with dysfunctional or slow CYP2A6 enzymes would show ________ build up of nicotine and find it _______ to quit.

Antabuse (Disulfiram) acts to block which of the following:

Which of the following enzymes is greatly increased with hemolysis?

Select all that applies. You are putting an athlete through the Functional Movement Screening. To do the Hurdle Step correctly it requires: 

Which medications are specifically indicated for triglyceride lowering in addition to an optimally dosed LDL-C lowering agent? (These medications are not indicated for LDLc lowering)

Significantly elevated serum amylase with normal urine amylase indicates:

Presented below is information related to Wise Company at December 31, 2017, the end of its first year of operations. Ignore income tax effects.                   Sales revenue                                                                                $775,000                  Cost of goods sold                                                                           350,000                  Selling and administrative expenses                                              125,000                  Gain on sale of investment                                                               75,000                  Unrealized gain on available-for-sale investments                          25,000                  Interest expense                                                                                15,000                  Loss on discontinued operations                                                       30,000                  Allocation to noncontrolling interest                                               100,000                  Dividends declared and paid                                                              12,000 After accounting for the Allocation to noncontrolling interest ($100,000), what is the Net income attributable to Wise Company’s controlling stockholders?

A value for GGT 30 U/L is: